首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1550565

分子诊断市场：按产品类型、按应用、按最终用户、按地区

Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography

出版日期: 2024年08月14日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球分子诊断市场预计到2024年将达到163.3亿美元，预计2031年将达到365.5亿美元，2024年至2031年复合年增长率为12.2%。

报告范围		报告详情
基准年	2023年	2024年市场规模	163.3亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	12.20%	2031年价值预测	365.5亿美元

图：2024 年按地区分類的分子诊断市场占有率(%)

分子诊断是一个不断发展的领域，它在分子层面上分析生物标记（biomarkers），以测试疾病、预测风险并确定新的治疗方法。分子诊断已成为现代医疗保健的基本工具，帮助临床医生检测和监测疾病并确定治疗策略。透过 DNA定序和聚合酵素链锁反应(PCR) 等技术检测生物标记的能力彻底改变了医学检测并大大改善了患者的治疗结果。分子诊断技术的进步，加上基因定序成本的下降，正在推动其在各种应用领域的广泛使用，包括传染病检查、肿瘤学和个人化医疗。持续的研究和开发预计将进一步扩大分析能力，并有助于持续的市场扩张。

市场动态：

由于多种因素，全球分子诊断市场正在经历强劲成长。世界各地的慢性病和感染疾病不断增加，增加了对先进诊断技术的需求。分子诊断测试可以比传统方法更快、更准确地检测疾病。对个人化医疗和伴同性诊断不断增长的需求也是一个关键驱动因素，因为分子测试有助于为个别患者确定最有效的治疗方法。随着技术的进步，分子诊断能力不断扩展，实现高通量筛检、自动化工作流程和分散测试环境。然而，测试设备的高成本和技术纯熟劳工的缺乏正在限制市场的成长。定序成本的持续降低以及可携式、易于使用的仪器的开发正在开闢新的应用机会，特别是在分散的照护现场环境中。

本研究的主要特点

该报告对全球分子诊断市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球分子诊断市场的主要企业。

本研究涵盖的主要企业包括 Abbott Laboratories、Becton、Dickinson and Company、Biomerieux SA、Danaher Corporation、Diasorin SPA、Hologic Inc.、QIAGEN NV 和 Roche Diagnostics。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球分子诊断市场的各种策略矩阵，将有助于相关人员做出决策。

Hoffmann-La Roche Ltd
Illumina, Inc.
Hologic, Inc.
Agilent Technologies Inc.
Qiagen NV
Myriad Genetics
Becton, Dickinson and Company
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation（Beckman Coulter Inc.）
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp（Monogram Biosciences）
Novartis AG

第九章分析师建议

第10章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI1545

The global molecular diagnostics market is estimated to be valued at USD 16.33 Billion in 2024 and is expected to reach USD 36.55 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.33 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.20%	2031 Value Projection:	US$ 36.55 Bn

Figure. Molecular Diagnostics Market Share (%), By Region 2024

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics:

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study:

This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Detailed Segmentation-

By Product Type
- Reagents & Kits
- Instruments
By Application
- Oncology
- Genetic Testing
- Microbiology
- STDs
- Blood Screening
- Virology
- Tissue Typing
- Prenatal Diagnosis
- Others
By End-user
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Point-of-Care Settings
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Players Insights
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Hologic, Inc.
- Agilent Technologies Inc.
- Qiagen N.V.
- Myriad Genetics
- Becton, Dickinson and Company
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter Inc.)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Johnson & Johnson
- Alere Inc.
- Cepheid
- Gen-Probe Incorporated
- LabCorp (Monogram Biosciences)
- Novartis AG

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Molecular Diagnostics Market, By Product Type
- Global Molecular Diagnostics Market, By Application
- Global Molecular Diagnostics Market, By End-User
- Global Molecular Diagnostics Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Molecular Diagnostics Market, By Product Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
STDs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Virology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Point-of-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa

8. COMPETITIVE LANDSCAPE

Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation (Beckman Coulter Inc.)
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp (Monogram Biosciences)
Novartis AG

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

分子诊断市场：按产品类型、按应用、按最终用户、按地区